These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8251396)

  • 1. Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.
    Longo G; Natoli C; Rafanelli D; Tinari N; Morfini M; Rossi-Ferrini P; D'Ostilio N; Iacobelli S
    Br J Haematol; 1993 Sep; 85(1):207-9. PubMed ID: 8251396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.
    Natoli C; Dianzani F; Mazzotta F; Balocchini E; Pierotti P; Antonelli G; Iacobelli S
    J Acquir Immune Defic Syndr (1988); 1993 Apr; 6(4):370-5. PubMed ID: 8095982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
    Briggs NC; Natoli C; Tinari N; D'Egidio M; Goedert JJ; Iacobelli S
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):811-6. PubMed ID: 7504933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
    Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
    Senaldi G; Peakman M; Natoli C; Hussain MJ; Gallati H; McManus T; Vergani D; Iacobelli S
    J Infect; 1994 Jan; 28(1):31-9. PubMed ID: 8163831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression.
    Iacobelli S; Natoli C; D'Egidio M; Tamburrini E; Antinori A; Ortona L
    J Infect Dis; 1991 Oct; 164(4):819. PubMed ID: 1894946
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of tumor-associated 90K-antigen in human breast cancer: no correlation with prognosis and response to first-line therapy with tamoxifen.
    Foekens JA; Klijn JG; Natoli C; van Putten WL; Di Stefano P; Look MP; Portengen H; Iacobelli S
    Int J Cancer; 1995 Apr; 64(2):130-4. PubMed ID: 7615355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV).
    Natoli C; Ortona L; Tamburrini E; Tinari N; Di Stefano P; D'Egidio M; Ghinelli F; Sighinolfi L; D'Ostilio N; Piazza M
    Anticancer Res; 1994; 14(3B):1457-60. PubMed ID: 8067721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-2 microglobulin as a predictor of prognosis in HIV-infected men with haemophilia: a proposed strategy for use in clinical care.
    Sabin CA; Phillips AN; Lee CA; Elford J; Timms A; Bofill M; Janossy G
    Br J Haematol; 1994 Feb; 86(2):366-71. PubMed ID: 7911035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of a novel circulating serum 90K antigen in breast cancer.
    Iacobelli S; Sismondi P; Giai M; D'Egidio M; Tinari N; Amatetti C; Di Stefano P; Natoli C
    Br J Cancer; 1994 Jan; 69(1):172-6. PubMed ID: 8286203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer.
    Zeimet AG; Natoli C; Herold M; Fuchs D; Windbichler G; Daxenbichler G; Iacobelli S; Dapunt O; Marth C
    Int J Cancer; 1996 Sep; 68(1):34-8. PubMed ID: 8895537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.
    Sabin CA; Griffioen A; Yee TT; Emery VC; Herrero-Martinez E; Phillips AN; Lee CA
    Lancet; 2002 Nov; 360(9345):1546-51. PubMed ID: 12443592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age dependency of the progression of HIV disease in haemophiliacs; predictive value of T cell subset and neopterin measurements.
    Ujhelyi E; Fuchs D; Králl G; Zimonyi I; Berkessy S; Bujdosó S; Pálóczi K; Mihalik R; Füst G; Wachter H
    Immunol Lett; 1990 Oct; 26(1):67-73. PubMed ID: 2276763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secreted tumor-associated antigen 90K is a potent immune stimulator.
    Ullrich A; Sures I; D'Egidio M; Jallal B; Powell TJ; Herbst R; Dreps A; Azam M; Rubinstein M; Natoli C
    J Biol Chem; 1994 Jul; 269(28):18401-7. PubMed ID: 8034587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus (HIV) infection in haemophiliacs: long-term prognostic significance of the HIV serologic pattern.
    Raska K; Kim HC; Raska K; Martin E; Raskova J; Saidi P
    Clin Exp Immunol; 1989 Jul; 77(1):1-6. PubMed ID: 2504517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection.
    Reddy MM; Grieco MH
    Int J STD AIDS; 1991; 2(2):128-32. PubMed ID: 2043705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin.
    Goudsmit J; Paul DA
    Epidemiol Infect; 1987 Dec; 99(3):701-10. PubMed ID: 3428375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.
    Aledort LM; Hilgartner MW; Pike MC; Gjerset GF; Koerper MA; Lian EY; Lusher JM; Mosley JW
    BMJ; 1992 Jan; 304(6821):212-6. PubMed ID: 1346752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of acquired immune deficiency syndrome (AIDS) and of AIDS related complex (ARC) in hemophiliacs seropositive for more than 5 years.
    Stain C; Pabinger-Fasching I; Guggenberger K; Köller U; Stain M; Hartl H; Heinz F; Mayerhofer S; Kyrle PA; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):354-6. PubMed ID: 2799750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.